21 results

• Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker

  March 12, 2025

  Irvin Jackson

  A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications.

• BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker

  March 5, 2025

  Irvin Jackson

  A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker.

• Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court

  February 21, 2025

  Irvin Jackson

  A federal judge has issued pretrial schedules for the first two BioZorb lawsuits to go before juries starting in September, calling for the parties to outline all the issues of contention, witnesses and facts to be presented during the bellwether early test cases.

• Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases

  February 12, 2025

  Irvin Jackson

  A federal judge has rejected plaintiffs' request to reopen the discovery and deposition process in BioZorb lawsuits following last October's global recall of the tissue markers.

• Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications

  February 4, 2025

  Irvin Jackson

  A lawsuit filed by six women claim the recalled BioZorb implant was defectively designed, causing pain, infections, swelling and fears of a return of their breast cancer.

• FDA Issues Warning Letter Over Recalled BioZorb Tissue Marker Manufacturing Problems

  January 29, 2025

  Irvin Jackson

  Investigators indicate that Hologic failed to properly address numerous problems with the design of the BioZorb tissue marker, which was recalled in October following numerous complication reports.

• BioZorb Lawsuits Over Breast Marker Complications Set for Trial in Sept. 2025 and Jan. 2026

  January 22, 2025

  Irvin Jackson

  A federal judge has set the first two dates for BioZorb lawsuit bellwether trials, with the first claims slated to go before juries Sept. 8, 2025 and Jan. 20, 2026.

• Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment

  January 9, 2025

  Irvin Jackson

  In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

• BioZorb Lawyers Propose Four Lawsuits Over Recalled Tissue Marker To Prepare for Trials Starting in Sept. 2025

  December 23, 2024

  Irvin Jackson

  A group of four BioZorb lawsuits have been selected for early bellwether trials, which are expected to begin in September 2025.

• Problems With Recalled BioZorb Markers Could Cause Severe Injury or Death, FDA Warns

  December 19, 2024

  Irvin Jackson

  The FDA is giving a recent BioZorb marker recall a class I designation, indicating the federal agency believes problems with the device, implanted to assist in targeted therapy in breast cancer patients, can cause serious injuries and potentially death.